These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 26780757)

  • 1. [Bridging in patients with long-term oral anticoagulation - new recommendations].
    Krabbe B; Bauersachs RM
    Dtsch Med Wochenschr; 2016 Feb; 141(3):157-60. PubMed ID: 26780757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bridging: Perioperative management of chronic anticoagulation or antiplatelet therapy].
    Nowak-Göttl U; Langer F; Limperger V; Mesters R; Trappe RU
    Dtsch Med Wochenschr; 2014 Jun; 139(24):1301-6. PubMed ID: 24892468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bridging anticoagulation in patients receiving vitamin K antagonists : Current status].
    Schellong SM; Riess H; Spannagl M; Omran H; Schwarzbach M; Langer F; Gogarten W; Bramlage P; Bauersachs RM
    Internist (Berl); 2018 Jul; 59(7):744-752. PubMed ID: 29946874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Periprocedural bridging therapy in patients receiving chronic oral anticoagulation therapy.
    Spyropoulos AC; Bauersachs RM; Omran H; Cohen M
    Curr Med Res Opin; 2006 Jun; 22(6):1109-22. PubMed ID: 16846544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Periprocedural heparin bridging in patients receiving vitamin K antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates.
    Siegal D; Yudin J; Kaatz S; Douketis JD; Lim W; Spyropoulos AC
    Circulation; 2012 Sep; 126(13):1630-9. PubMed ID: 22912386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bridging anticoagulation in patients receiving vitamin K antagonists : Current status].
    Schellong SM; Riess H; Spannagl M; Omran H; Schwarzbach M; Langer F; Gogarten W; Bramlage P; Bauersachs RM
    Anaesthesist; 2018 Aug; 67(8):599-606. PubMed ID: 29926118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Periprocedural management of anticoagulation in patients taking novel oral anticoagulants: Review of the literature and recommendations for specific populations and procedures.
    Mar PL; Familtsev D; Ezekowitz MD; Lakkireddy D; Gopinathannair R
    Int J Cardiol; 2016 Jan; 202():578-85. PubMed ID: 26447666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
    Ansell J; Hirsh J; Poller L; Bussey H; Jacobson A; Hylek E
    Chest; 2004 Sep; 126(3 Suppl):204S-233S. PubMed ID: 15383473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bridging therapy and oral anticoagulation: current and future prospects.
    Spyropoulos AC
    Curr Opin Hematol; 2010 Sep; 17(5):444-9. PubMed ID: 20613508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The current status of bridging anticoagulation.
    Patel JP; Arya R
    Br J Haematol; 2014 Mar; 164(5):619-29. PubMed ID: 24224681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Striking a balance between the risks and benefits of anticoagulation bridge therapy in patients with atrial fibrillation: clinical updates and remaining controversies.
    Garwood CL; Hwang JM; Moser LR
    Pharmacotherapy; 2011 Dec; 31(12):1208-20. PubMed ID: 22122182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The management of patients who require temporary reversal of vitamin K antagonists for surgery: a practical guide for clinicians.
    Mannucci C; Douketis JD
    Intern Emerg Med; 2006; 1(2):96-104. PubMed ID: 17111781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bridging with enoxaparin using a half-therapeutic dose regimen: safety and efficacy.
    Klamroth R; Gottstein S; Essers E; Landgraf H
    Vasa; 2010 Aug; 39(3):243-8. PubMed ID: 20737383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A practical approach for bridging anticoagulation after mechanical heart valve replacement.
    Steger V; Bail DH; Graf D; Walker T; Rittig K; Ziemer G
    J Heart Valve Dis; 2008 May; 17(3):335-42. PubMed ID: 18592932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-vitamin K oral anticoagulants in atrial fibrillation: Where are we now?
    Dzeshka MS; Lip GY
    Trends Cardiovasc Med; 2015 May; 25(4):315-36. PubMed ID: 25440108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis: effect of patient self-testing and self-management of long-term anticoagulation on major clinical outcomes.
    Bloomfield HE; Krause A; Greer N; Taylor BC; MacDonald R; Rutks I; Reddy P; Wilt TJ
    Ann Intern Med; 2011 Apr; 154(7):472-82. PubMed ID: 21464349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on perioperative bridging in patients on chronic oral anticoagulation.
    Faltas B; Kouides PA
    Expert Rev Cardiovasc Ther; 2009 Dec; 7(12):1533-9. PubMed ID: 19954315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perioperative bridging interruption with heparin for the patient receiving long-term anticoagulation.
    Spyropoulos AC; Turpie AG
    Curr Opin Pulm Med; 2005 Sep; 11(5):373-9. PubMed ID: 16093808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Duration of antivitamin K therapy in venous thromboembolic disease].
    Ferrari E; Baudouy M; Morand P
    Arch Mal Coeur Vaiss; 1995 Dec; 88(12):1891-4. PubMed ID: 8729371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bleeding Risk, Management and Outcome in Patients Receiving Non-VKA Oral Anticoagulants (NOACs).
    Werth S; Breslin T; NiAinle F; Beyer-Westendorf J
    Am J Cardiovasc Drugs; 2015 Aug; 15(4):235-42. PubMed ID: 25940651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.